Virginia Commonwealth University Leads Research to Improve Access to AIDS Drugs
June 25, 2014
This article was reported by the News & Observer.
News & Observer reported that officials from Richmond's Virginia Commonwealth University (VCU) said a $4.4 million grant from the Bill & Melinda Gates Foundation is allowing VCU to lead an effort with other research universities to supply developing countries with affordable access to AIDS drugs. The project -- known as the Medicine for All Initiative -- is made up of researchers from the University of Washington, Florida State University, and Massachusetts Institute of Technology, and will focus on improving costs for the drug nevirapine. According to officials, the collaboration will work to develop new synthetic and manufacturing methods for the drug, considered by the World Health Organization to be a first-line therapy for the treatment of AIDS.
The Medicines Patent Pool (MPP) Broadens Collaboration With Gilead Sciences: Signs License for Phase III Medicine Tenofovir Alafenamide (TAF)
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)